Suvro Ghosh - Founder, has worked in the American clinical research system, at the federal & state levels for 10 years, primarily in the area of patient outcome improvement.
Dr. Robert Clark - Co-founder, is the AVP for Clinical Research & Director, IIMS at the UTHSCSA, Texas. He has co-founded a successful biotechnology company, Genkyotex, currently valued at $250+ Million.
Ushering in the future, a biotech company, ClinZen, is retooling the next generation clinical trial space. With the suite of products ClinZen has to offer, the time to complete a trial and resource consumption can be reduced by half or more, typically impacting the business bottom line and the people awaiting the intervention, favorably.
Product/Service Descriptions
Danamorph (Codename)
ClinZen's solution is an enterprise class Clinical Trial Management System (CTMS) which tackles the entire clinical and operational modalities end to end, with a fully mobile capable platform – bringing iPad, Android, PC, Mac and Linux under one roof. As a multi-platform product, our product will work like a solution created in that operating system, using that platforms capabilities. Perched on Cloud hosted under Software as a Service, it dramatically lowers the cost to the end consumer. Backed with a unique feature-set, ClinZen is filing for several patents for developing unique interface, workflow and software layer differentiators.
Connect to Social Platform
Your LetsVenture account is not connected to {{portal}}.
Connect to {{portal}}